Medical research and drug discovery have been my passion since I was a teenager after my father became seriously ill.   Over the last 25 years in academia and pharmaceutical R&D, I have had the privilege of working with great scientists and teams to discover and develop agency-approved medicines that are helping patients. During my career, I have cross-trained in basic academic research, pharmaceutical discovery, and clinical development across disease areas and business development.  

 

I received my Ph.D. in endocrine physiology from the Royal Postgraduate Medical School at Imperial College in London. After post-doctoral training at Imperial and the Ludwig Institute for Cancer Research (UCL), I joined Ferring Pharmaceuticals in R&D, working across sites in the UK and US.  

 

I joined Merck Research Labs in 2005 and held roles with increasing responsibility in clinical pharmacology as a development team leader working on first-in-human studies through late-stage label studies before joining Discovery Preclinical & Early Development as a therapeutic area lead and search and evaluation lead in business development.

​

I am now the President of R&D, Therapeutics at Schrödinger, leading the company’s 150-person therapeutics group. I am responsible for preclinical drug discovery, translational research, early clinical development, and drug discovery business development and collaborations. We integrate accurate physics-based methods and the scale of machine learning in structure-based drug design. 

​

A list of my scientific publications can be found on Google Scholar

​

In my spare time, I enjoy writing, photography, finding new ways to teach science and technology, and mentoring people of all ages.